- Home
- ENSC vs STSS Comparison
ENSC vs STSS Comparison
Compare ENSC & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- STSS
- Stock Information
- Founded
- ENSC 2003
- STSS 2017
- Country
- ENSC United States
- STSS United States
- Employees
- ENSC N/A
- STSS N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- STSS Medical/Dental Instruments
- Sector
- ENSC Health Care
- STSS Health Care
- Exchange
- ENSC Nasdaq
- STSS Nasdaq
- Market Cap
- ENSC 5.2M
- STSS 5.8M
- IPO Year
- ENSC N/A
- STSS 2022
- Fundamental
- Price
- ENSC $2.15
- STSS $5.41
- Analyst Decision
- ENSC
- STSS
- Analyst Count
- ENSC 0
- STSS 0
- Target Price
- ENSC N/A
- STSS N/A
- AVG Volume (30 Days)
- ENSC 874.4K
- STSS 63.4K
- Earning Date
- ENSC 08-13-2025
- STSS 08-26-2025
- Dividend Yield
- ENSC N/A
- STSS N/A
- EPS Growth
- ENSC N/A
- STSS N/A
- EPS
- ENSC N/A
- STSS N/A
- Revenue
- ENSC $6,224,081.00
- STSS N/A
- Revenue This Year
- ENSC N/A
- STSS N/A
- Revenue Next Year
- ENSC $1,381.48
- STSS N/A
- P/E Ratio
- ENSC N/A
- STSS N/A
- Revenue Growth
- ENSC 256.35
- STSS N/A
- 52 Week Low
- ENSC $1.62
- STSS $3.36
- 52 Week High
- ENSC $14.67
- STSS $2,145.00
- Technical
- Relative Strength Index (RSI)
- ENSC 49.40
- STSS 51.58
- Support Level
- ENSC $1.99
- STSS $5.29
- Resistance Level
- ENSC $2.25
- STSS $6.73
- Average True Range (ATR)
- ENSC 0.17
- STSS 0.57
- MACD
- ENSC -0.00
- STSS 0.06
- Stochastic Oscillator
- ENSC 47.62
- STSS 56.89
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.